Health Care & Life Sciences » Biotechnology | Hemispherx Biopharma Inc.

Hemispherx Biopharma Inc. | Ownership

Companies that own Hemispherx Biopharma Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Sabby Capital LLC
1,938,374
4.11%
1,938,374
0.26%
06/30/2018
The Vanguard Group, Inc.
467,574
0.99%
24,102
0%
06/30/2018
BlackRock Fund Advisors
458,406
0.97%
1,068
0%
06/30/2018
Geode Capital Management LLC
74,832
0.16%
0
0%
06/30/2018
Citadel Advisors LLC
55,020
0.12%
-145,729
0%
06/30/2018
Creative Planning, Inc.
40,001
0.09%
0
0%
06/30/2018
Northern Trust Investments, Inc.
31,933
0.07%
0
0%
06/30/2018
Virtu Financial BD LLC
30,718
0.07%
-3,612
0%
06/30/2018
Guggenheim Funds Investment Advisors LLC
19,614
0.04%
119
0%
03/31/2018
UBS Securities LLC
19,064
0.04%
18,944
0%
06/30/2018

About Hemispherx Biopharma

View Profile
Address
2117 South West Highway 484
Ocala Florida 32801
United States
Employees -
Website http://www.hemispherx.net
Updated 09/14/2018
Hemispherx Biopharma, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.